Do analysts prefer VANI or CNXU?

Vivani Medical presently has a consensus target price of $3.50, suggesting a potential upside of 218.18%. Given Vivani Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Vivani Medical is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivani Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, VANI or CNXU?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vivani Medical N/A N/A -$26.61M -$0.40 N/A Conexeu Sciences N/A N/A N/A N/A N/A

Is VANI or CNXU more profitable?

Conexeu Sciences' return on equity of 0.00% beat Vivani Medical's return on equity. Company Net Margins Return on Equity Return on Assets Vivani Medical N/A -264.04% -79.85% Conexeu Sciences N/A N/A N/A

Does the media prefer VANI or CNXU?

In the previous week, Conexeu Sciences had 1 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for Conexeu Sciences and 2 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 0.93 beat Conexeu Sciences' score of 0.44 indicating that Vivani Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivani Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to VANI or KIDS?

In the previous week, OrthoPediatrics had 1 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for OrthoPediatrics and 2 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 0.93 beat OrthoPediatrics' score of 0.63 indicating that Vivani Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivani Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Vivani Medical (VANI) Competitors

$1.10 -0.03 (-2.65%)

Closing price 04:00 PM Eastern

Extended Trading

$1.11 +0.01 (+0.91%)

As of 07:36 PM Eastern

Compare

VANI vs. COCH, CNXU, KIDS, CLPT, and DCTH

Should you buy Vivani Medical stock or one of its competitors? MarketBeat compares Vivani Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Vivani Medical include Envoy Medical (COCH), Conexeu Sciences (CNXU), OrthoPediatrics (KIDS), ClearPoint Neuro (CLPT), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.

How does Vivani Medical compare to Envoy Medical?

Vivani Medical (NASDAQ:VANI) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Vivani Medical presently has a consensus target price of $3.50, indicating a potential upside of 218.18%. Envoy Medical has a consensus target price of $2.50, indicating a potential upside of 298.15%. Given Envoy Medical's higher possible upside, analysts plainly believe Envoy Medical is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Envoy Medical	-9,875.64%	N/A	-177.92%

In the previous week, Vivani Medical had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Vivani Medical and 1 mentions for Envoy Medical. Vivani Medical's average media sentiment score of 0.93 beat Envoy Medical's score of 0.62 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Vivani Medical	Positive
Envoy Medical	Positive

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Envoy Medical	$240K	201.14	-$23.76M	-$1.01	N/A

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by insiders. Comparatively, 7.1% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Vivani Medical has a beta of 2.31, suggesting that its stock price is 131% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Summary

Vivani Medical beats Envoy Medical on 7 of the 12 factors compared between the two stocks.

How does Vivani Medical compare to Conexeu Sciences?

Vivani Medical (NASDAQ:VANI) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

In the previous week, Conexeu Sciences had 1 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for Conexeu Sciences and 2 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 0.93 beat Conexeu Sciences' score of 0.44 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vivani Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

6.8% of Vivani Medical shares are held by institutional investors. 53.3% of Vivani Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Vivani Medical presently has a consensus target price of $3.50, suggesting a potential upside of 218.18%. Given Vivani Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Vivani Medical is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A

Conexeu Sciences' return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Conexeu Sciences	N/A	N/A	N/A

Summary

Vivani Medical beats Conexeu Sciences on 6 of the 9 factors compared between the two stocks.

How does Vivani Medical compare to OrthoPediatrics?

Vivani Medical (NASDAQ:VANI) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Vivani Medical has a net margin of 0.00% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

Vivani Medical has a beta of 2.31, meaning that its share price is 131% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

In the previous week, OrthoPediatrics had 1 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for OrthoPediatrics and 2 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 0.93 beat OrthoPediatrics' score of 0.63 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vivani Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Vivani Medical has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
OrthoPediatrics	$236.35M	1.94	-$39.65M	-$1.68	N/A

Vivani Medical presently has a consensus price target of $3.50, suggesting a potential upside of 218.18%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 37.17%. Given Vivani Medical's higher possible upside, analysts plainly believe Vivani Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

Summary

OrthoPediatrics beats Vivani Medical on 8 of the 15 factors compared between the two stocks.

How does Vivani Medical compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

ClearPoint Neuro presently has a consensus price target of $18.00, suggesting a potential upside of 33.93%. Vivani Medical has a consensus price target of $3.50, suggesting a potential upside of 218.18%. Given Vivani Medical's higher possible upside, analysts plainly believe Vivani Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Vivani Medical has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -71.57%. ClearPoint Neuro's return on equity of -140.96% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Vivani Medical	N/A	-264.04%	-79.85%

In the previous week, Vivani Medical had 1 more articles in the media than ClearPoint Neuro. MarketBeat recorded 2 mentions for Vivani Medical and 1 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.87 beat Vivani Medical's score of 0.93 indicating that ClearPoint Neuro is being referred to more favorably in the media.

Company	Overall Sentiment
ClearPoint Neuro	Very Positive
Vivani Medical	Positive

30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 6.9% of ClearPoint Neuro shares are held by insiders. Comparatively, 53.3% of Vivani Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

ClearPoint Neuro has higher revenue and earnings than Vivani Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	10.90	-$25.54M	-$1.01	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A

ClearPoint Neuro has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.31, suggesting that its share price is 131% more volatile than the broader market.

Summary

ClearPoint Neuro beats Vivani Medical on 8 of the 15 factors compared between the two stocks.

How does Vivani Medical compare to Delcath Systems?

Vivani Medical (NASDAQ:VANI) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Vivani Medical has a beta of 2.31, suggesting that its share price is 131% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 53.3% of Vivani Medical shares are held by company insiders. Comparatively, 19.4% of Delcath Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Delcath Systems has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Delcath Systems	$85.23M	4.75	$2.70M	$0.01	1,172.00

Vivani Medical currently has a consensus target price of $3.50, suggesting a potential upside of 218.18%. Delcath Systems has a consensus target price of $22.50, suggesting a potential upside of 91.98%. Given Vivani Medical's higher probable upside, research analysts plainly believe Vivani Medical is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43

Delcath Systems has a net margin of 0.62% compared to Vivani Medical's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Delcath Systems	0.62%	0.51%	0.46%

In the previous week, Vivani Medical had 1 more articles in the media than Delcath Systems. MarketBeat recorded 2 mentions for Vivani Medical and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.89 beat Vivani Medical's score of 0.93 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Vivani Medical	Positive
Delcath Systems	Very Positive

Summary

Delcath Systems beats Vivani Medical on 11 of the 15 factors compared between the two stocks.

Get Vivani Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VANI vs. The Competition

Export

Metric	Vivani Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$97.45M	$2.98B	$6.49B	$11.98B
Dividend Yield	N/A	1.78%	2.67%	5.57%
P/E Ratio	-2.75	18.07	23.85	24.45
Price / Sales	N/A	757.81	572.24	136.74
Price / Cash	N/A	56.09	43.20	54.62
Price / Book	5.50	4.01	10.66	6.80
Net Income	-$26.61M	$75.85M	$3.56B	$337.76M
7 Day Performance	-6.78%	1.07%	0.05%	2.08%
1 Month Performance	-3.51%	-3.27%	0.37%	3.16%
1 Year Performance	-7.56%	20.00%	22.73%	27.78%

Vivani Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VANI Vivani Medical	3.6895 of 5 stars	$1.10 -2.7%	$3.50 +218.2%	-5.0%	$97.45M	N/A	N/A	20	Analyst Forecast
COCH Envoy Medical	2.4649 of 5 stars	$0.70 -1.4%	$2.50 +259.7%	-54.6%	$53.43M	$240K	N/A	34	News Coverage
CNXU Conexeu Sciences	N/A	$17.14 +1.8%	N/A	N/A	$435.15M	N/A	N/A	4	Short Interest Increase
KIDS OrthoPediatrics	3.0373 of 5 stars	$16.77 -0.3%	$24.44 +45.8%	-19.3%	$430.53M	$236.35M	N/A	200	Positive News
CLPT ClearPoint Neuro	2.8388 of 5 stars	$13.25 +7.1%	$18.00 +35.9%	+7.7%	$398.27M	$36.97M	N/A	110	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VANI) was last updated on 6/12/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vivani Medical (VANI) Competitors

VANI vs. COCH, CNXU, KIDS, CLPT, and DCTH

How does Vivani Medical compare to Envoy Medical?

Summary

How does Vivani Medical compare to Conexeu Sciences?

Summary

How does Vivani Medical compare to OrthoPediatrics?

Summary

How does Vivani Medical compare to ClearPoint Neuro?

Summary

How does Vivani Medical compare to Delcath Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI vs. The Competition

Vivani Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vivani Medical (VANI) Competitors

VANI vs. COCH, CNXU, KIDS, CLPT, and DCTH

How does Vivani Medical compare to Envoy Medical?

Do analysts prefer VANI or COCH?

Is VANI or COCH more profitable?

Does the media prefer VANI or COCH?

Which has preferable valuation and earnings, VANI or COCH?

Do institutionals and insiders have more ownership in VANI or COCH?

Which has more risk & volatility, VANI or COCH?

Summary

How does Vivani Medical compare to Conexeu Sciences?

Does the media prefer VANI or CNXU?

Do insiders and institutionals have more ownership in VANI or CNXU?

Do analysts prefer VANI or CNXU?

Which has higher valuation & earnings, VANI or CNXU?

Is VANI or CNXU more profitable?

Summary

How does Vivani Medical compare to OrthoPediatrics?

Is VANI or KIDS more profitable?

Which has more risk & volatility, VANI or KIDS?

Does the media refer more to VANI or KIDS?

Do institutionals & insiders hold more shares of VANI or KIDS?

Which has stronger valuation & earnings, VANI or KIDS?

Do analysts rate VANI or KIDS?

Summary

How does Vivani Medical compare to ClearPoint Neuro?

Do analysts recommend CLPT or VANI?

Is CLPT or VANI more profitable?

Does the media favor CLPT or VANI?

Do institutionals and insiders have more ownership in CLPT or VANI?

Which has stronger valuation & earnings, CLPT or VANI?

Which has more risk and volatility, CLPT or VANI?

Summary

How does Vivani Medical compare to Delcath Systems?

Which has more volatility and risk, VANI or DCTH?

Do institutionals & insiders have more ownership in VANI or DCTH?

Which has better earnings and valuation, VANI or DCTH?

Do analysts recommend VANI or DCTH?

Is VANI or DCTH more profitable?

Does the media favor VANI or DCTH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI vs. The Competition

Vivani Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools